NCT05259709 2025-09-11A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With CemiplimabRegeneron PharmaceuticalsPhase 1 Recruiting50 enrolled
NCT06090266 2025-01-07A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer AgentsOncoResponse, Inc.Phase 1/2 Recruiting168 enrolled